NYSE:NNVC

NanoViricides Stock Forecast, Price & News

$2.04

-0.07 (-3.32%)

(As of 06/24/2022 12:00 AM ET)

Add

Compare

Today's Range: $2.04
▼
$2.19
50-Day Range: $1.12
▼
$2.60
52-Week Range: $1.04
▼
$7.86

Volume: 39,794 shs
Average Volume: 33,050 shs
Market Capitalization: $23.56 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive NNVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter.

NNVC Stock Forecast (MarketRank)

Overall MarketRank^™

0.13 out of 5 stars

Medical Sector

1373rd out of 1,411 stocks

Pharmaceutical Preparations Industry

660th out of 672 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for NanoViricides.

0.0 Community Rank

Outperform Votes
NanoViricides has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
NanoViricides has received 17 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
NanoViricides has received 100.00% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about NanoViricides and other stocks. Vote “Outperform” if you believe NNVC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NNVC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
NanoViricides does not currently pay a dividend.
Dividend Growth
NanoViricides does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, NanoViricides insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 4.20% of the stock of NanoViricides is held by insiders.
Percentage Held by Institutions
Only 9.59% of the stock of NanoViricides is held by institutions.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of NanoViricides is -2.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of NanoViricides is -2.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
NanoViricides has a P/B Ratio of 0.78. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About NanoViricides (NYSE:NNVC)

NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.

June 18, 2022 | americanbankingnews.com

NanoViricides (NYSE:NNVC) Now Covered by Analysts at StockNews.com

June 9, 2022 | americanbankingnews.com

NanoViricides (NYSE:NNVC) Receives New Coverage from Analysts at StockNews.com

June 1, 2022 | americanbankingnews.com

StockNews.com Initiates Coverage on NanoViricides (NYSE:NNVC)

May 26, 2022 | nasdaq.com

Pre-market Movers: NTNX, WKME, SNOW, ISPC, NNVC…

See More Headlines

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:NNVC
CUSIP: N/A
CIK: 1379006
Web: www.nanoviricides.com
Phone: (203) 937-6137
Fax: 203-859-5095
Employees: 17
Year Founded: N/A

Company Calendar

Last Earnings: 5/17/2022
Today: 6/26/2022
Fiscal Year End: 6/30/2022

Profitability

EPS (Most Recent Fiscal Year): ($0.740010)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-8.82 million
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -30.70%
Return on Assets: -30.16%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 41.21
Quick Ratio: 41.21

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.60 per share
Price / Book: 0.78

Miscellaneous

Outstanding Shares: 11,550,000
Free Float: 11,069,000
Market Cap: $23.56 million
Optionable: Optionable
Beta: 1.03

NanoViricides Frequently Asked Questions

How has NanoViricides' stock price performed in 2022?: NanoViricides' stock was trading at $2.11 at the beginning of the year. Since then, NNVC stock has decreased by 3.3% and is now trading at $2.04.
View the best growth stocks for 2022 here.
How were NanoViricides' earnings last quarter?: NanoViricides, Inc. (NYSE:NNVC) announced its earnings results on Tuesday, May, 17th. The company reported ($0.16) earnings per share for the quarter.
View NanoViricides' earnings history.
Who are NanoViricides' key executives?: NanoViricides' management team includes the following people:
Dr. Anil R. Diwan Ph.D., Exec. Chairman, Pres, CEO & Sec. (Age 63, Pay $400k)
Ms. Meeta R. Vyas B.S., M.B.A., SB, MBA, Chief Financial Officer (Age 63, Pay $129.6k)
Dr. Randall W. Barton Ph.D., Chief Scientific Officer & Chief Regulatory Officer (Age 75)
Who are some of NanoViricides' key competitors?: Some companies that are related to NanoViricides include Annovis Bio (ANVS), GT Biopharma (GTBP), NervGen Pharma (NGENF), Adagene (ADAG), TherapeuticsMD (TXMD), Endo International (ENDP), Trevi Therapeutics (TRVI), Ardelyx (ARDX), Alzamend Neuro (ALZN), Enlivex Therapeutics (ENLV), MEI Pharma (MEIP), Tiziana Life Sciences (TLSA), Synlogic (SYBX), Vicapsys Life Sciences (VICP) and Merrimack Pharmaceuticals (MACK).
View all of NNVC's competitors.

What is NanoViricides' stock symbol?: NanoViricides trades on the New York Stock Exchange (NYSE) under the ticker symbol "NNVC."
How do I buy shares of NanoViricides?: Shares of NNVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is NanoViricides' stock price today?: One share of NNVC stock can currently be purchased for approximately $2.04.
How much money does NanoViricides make?: NanoViricides (NYSE:NNVC) has a market capitalization of $23.56 million. The company earns $-8.82 million in net income (profit) each year or ($0.740010) on an earnings per share basis.
How many employees does NanoViricides have?: NanoViricides employs 17 workers across the globe.
How can I contact NanoViricides?: NanoViricides' mailing address is 1 Controls Dr, Shelton, Connecticut 06484-6153. The official website for NanoViricides is www.nanoviricides.com. The company can be reached via phone at (203) 937-6137, via email at [email protected], or via fax at 203-859-5095.

This page (NYSE:NNVC) was last updated on 6/26/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources